developmentstoday

Ask DT AI Audio Brief Videos Podcast +

Ask DT AI Audio Brief Videos Podcast

HomeTagsprostate cancer

#prostate cancer

All articles tagged with "prostate cancer"

Company

About Us
Advertise
Contact
Editorial Policy

Legal

Terms of Service
Privacy Policy
Cookie Policy
AI & Ethics Policy
Do Not Sell My Info
FAQ
Archive
Site Map

Discover

Newsletter
Ask DT AI
Audio Brief
Videos
Podcast
DT Premium

Connect

Twitter / X
Facebook
LinkedIn
YouTube
Instagram
TikTok
Flipboard
RSS Feed

© 2026 Developments Today. All rights reserved.

Prostate cancer drug shows promise in new clinical trial

Prostate Cancer Drug Trial Tests Targeted Protein Degradation

Bavdegalutamide is a PROTAC androgen-receptor degrader being tested for mCRPC.
The phase 1 study identified a 420-milligram daily dose as safe in previously treated patients.
Phase 2 findings showed promising early signals for tumor activity and pain, requiring further study.

DE

DT Editorial Team·Nov 4, 2026·via medicalxpress.com

More in Health→

Novel alpha radiopharmaceutical therapy shows promise in early-phase prostate cancer trial

Lead-212 Therapy Shows Early Signals in Advanced Prostate Cancer

Phase I trial enrolled 22 people with progressive advanced prostate cancer.
No dose-limiting toxicities were observed in the reported study results.
Eighty percent of participants had PSA declines of at least 50%.
The treatment is investigational and requires larger clinical trials.

DE

DT Editorial Team·Oct 28, 2026·via medicalxpress.com

More in Health→

Fewer US men are diagnosed with low-risk prostate cancer, and more of them now choose surveillance over treatment

US Prostate Cancer Care Shifts Further Toward Active Surveillance

Low-risk prostate cancer diagnoses fell in both SEER and VA data.
Most patients with low-risk disease now avoided immediate radiation or prostate removal.
The findings reflect a broad move to reduce overtreatment while monitoring appropriate patients.

DE

DT Editorial Team·Oct 26, 2026·via medicalxpress.com

More in Health→

Diagnostic test could help doctors refine prostate cancer treatment

Decipher Test May Refine Prostate Cancer Treatment

Researchers analyzed Decipher scores in real-world and STAMPEDE trial datasets.
Higher scores were associated with greater risks of metastasis and prostate-cancer death.
The score may help identify node-negative patients who benefit from added abiraterone.

DE

DT Editorial Team·Oct 24, 2026·via medicalxpress.com

More in Health→

Researchers identify new target to prevent aggressive form of prostate cancer

Researchers identify Sirt1 as target in aggressive prostate cancer

A Columbia-led study identified Sirt1 as a driver of neuroendocrine prostate cancer.
Blocking Sirt1 prevented NEPC tumor growth in mice.
The findings could inform future clinical work on treatment-resistant prostate cancer.

DE

DT Editorial Team·May 28, 2026·via medicalxpress.com

More in Health→

Screening modestly reduces prostate cancer deaths, review finds

PSA screening appears to cut prostate cancer deaths modestly, updated review finds

An updated Cochrane review says PSA screening likely reduces prostate cancer deaths.
The review estimates about two fewer prostate cancer deaths per 1,000 men screened.
Overdiagnosis and treatment-related harms remain major issues in screening decisions.

DE

DT Editorial Team·May 15, 2026·via medicalxpress.com

More in Health→

New Urine Test May Reduce Biopsies for Men on Prostate Cancer Surveillance

A study found the MPS2-AS urine test performed better than PSA-based testing and MRI for active surveillance.
The test could have avoided up to 64% of unnecessary repeat biopsies in the studied group.
Researchers say the approach may reduce invasive monitoring without delaying detection of higher-grade disease.

DE

DT Editorial Team·May 8, 2026·via medicalxpress.com

More in Health→

Stable PSA Readings May Miss Prostate Cancer Progression, Trial Analysis Finds

A large analysis of two clinical trials found scans can detect progression despite stable biomarkers.
The finding applies to patients treated with androgen receptor pathway inhibitors.
The result suggests biomarker stability alone may not be enough to rule out advancing disease.

DE

DT Editorial Team·Apr 27, 2026·via medicalxpress.com

More in Health→

Housing Assistance Linked to Better Two-Year Survival for Older Men With Prostate Cancer

Older men with prostate cancer receiving federal housing assistance reportedly had better two-year survival.
The comparison was made against demographically and clinically similar men without assistance.
The supplied source text is limited, so causal claims should be treated cautiously.

DE

DT Editorial Team·Apr 22, 2026·via medicalxpress.com

More in Health→

Research: Faster Recovery With Minimally Invasive Prostate Treatment (via miragenews.com)

Minimally Invasive Prostate Cancer Treatment Shows Faster Recovery in Trial

A randomized clinical trial focused on men with localized, intermediate-risk prostate cancer.
The minimally invasive treatment led to faster recovery.
Patients also reported less short-term impact on everyday life.

DE

DT Editorial Team·Apr 14, 2026·via medicalxpress.com

More in Health→

HRT skin patches match standard prostate cancer hormone therapy in UK trial

A UK trial found HRT patches matched standard injections in treating prostate cancer.
The patches were reported to cause fewer serious side effects.
The results were described as published in the New England Journal of Medicine.

DE

DT Editorial Team·Apr 8, 2026·via medicalxpress.com

More in Health→